Introduction
Noninvasive intermittent blood pressure monitoring was first developed 30 years ago.' It is now evolving from its former role as a somewhat esoteric research tool to becoming a clinically useful procedure for the evaluation of hypertensive patients. In this review we outline its historical development, compare noninvasive 24-hour ambulatory blood pressure monitoring with the other available methods of blood pressure assessment, and evaluate the current roles for the technique in the diagnosis and management of hypertension.
Historical backround
Arterial blood pressure may be measured directly by intra-arterial puncture, or indirectly by noninvasive means, by manual or automated techniques, and in stationary or ambulant subjects. The Reverend Steven Hales was the first to measure blood pressure directly in animals. He showed that blood rose to a height of over 8 feet in a glass tube placed in the artery of a horse. A device suitable for measuring human intra-arterial pressure was developed by Jean-Leonard Marie Poiseuille in 1828,3 but it was not until 1969 that the first report of automated intra-arterial blood pressure recording in unrestricted ambulant man was published. 4 The essential components for continuous intraarterial pressure measurement using the popular 'Oxford System'5 are a fine intra-arterial catheter (in the brachial or radial artery) constantly perfused, a miniaturized pressure tranducer and a magnetic tape recorder. This system can provide a complete accurate profile of blood pressure behaviour, measuring each individual beat over 24 hours, delineating beat-to-beat variability and circadian rhythms clearly in subjects performing normal daily activities. Due to its invasive nature, the impact of direct inter-arterial blood pressure recording on clinical practice has been limited.
Attention has thus turned to noninvasive or indirect techniques to obtain a profile of 24-hour blood pressure.
The first instrument for measuring blood pressure indirectly was devised by Jules Herisson in 1833, and consisted of a mercury reservoir covered by a rubber membrane from which a graduated glass column arose. The mercury bulb was compressed against the radial artery until the oscillations in the mercury column ceased, at which point systolic pressure was estimated. Many steps, too numerous to describe, have punctuated the development of modem indirect devices.6 Currently used devices use arm arterial occlusion7 and detect blood pressure level by Korotkov sound auscultation,8 oscillometry9 or ultrasonography.'0 These indirect techniques of blood pressure measurement may be utilized in three ways -for conventional measurement ofblood pressure in the clinic or surgery setting; for self-measurement of blood pressure usually in the home environment, and for automated measurement of blood pressure over the 24-hour period -each providing somewhat different information.
Clinical blood pressure measurements by doctors and nurses have been used since the turn of the century, but self-measurement ofblood pressure by the patient has only been extensively explored in the last decade.'1" '4 In 1962 Hinman and his colleagues described the first truly portable system for the intermittent noninvasive measurement of blood pressure in subjects performing their usual daily routine.' This system was developed commercially by the Remler company in California'" and consisted ofa batteryoperated recorder worn by the patient, a cuffwhich was inflated by the patient at predetermined intervals and a microphone strapped over the brachial artery. Blood pressures were recorded on a magnetic tape, which could be later decoded, and the pressure plotted over the period of recording.
Because the device depended on inflation by the subject, recordings were confined to waking hours and rarely spanned more than 12-14 hours. With the development ofcompact pumps and solid-state memory systems, the Remler system has been replaced by devices capable of automatically inflating the cuff and providing pressure profiles over 24 hours such as those illustrated in Figures  1-6 . The early models were noisy and bulky, but latterly they have become smaller, quieter and more 'patient friendly'. Also the number of such devices has increased. There are now at least 15 systems currently available'6 and many more in the developmental stages.
Noninvasive blood pressure monitoring systems suffer from the disadvantage that during measurement the subject must discontinue all activity and provide support for the arm, and hence the measurements are static rather than truely 'ambulatory'. Additionally only an intermittent, as opposed to a continuous record of 24-hour blood pressure behaviour is provided. Dispite these limitations noninvasive monitoring systems yield mean 24-hour values and diurnal/nocturnal patterns which are surprisingly close to those measured by continuous intra-arterial monitoring.l7
Some attempts have been made to develop systems that provide indirect continuous 24-hour blood pressure monitoring during rest and activity'8"9 -in short the equivalent of direct intra-arterial measurement without the inherent dangers of arterial catheterization -but no such system has as yet proved sufficiently accurate. Hence the remainder ofthis review will focus on the status of noninvasive intermittent 24-hour 'ambulatory' blood pressure monitoring.
Device validation
The instruments for noninvasive pressure monitoring are expensive, both in terms of capital and running costs. As a result, it has become increasingly important that devices are shown to be accurate. In order to minimize reliance on manufacturers' reports, two groups have published validation protocols, the Association for the firstly, the marked moment-to-moment variability of blood pressure;"2" and secondly a phenomena known as the white coat effect, whereby a subject responds to the circumstance of blood pressure measurement."5-7
The white coat phenomenon has been most forcefully demonstrated in two studies by Mancia and colleagues.45"' They showed that when a physician prepared to take a blood pressure reading with a mercury sphygmomanometer on one arm of the patient, there was a marked rise in intra-arterial pressure in the other arm, which persisted throughout the measurement procedure. The average rise in pressure evoked by the presence of a physician was 23/18 mmHg. White coat hypertension has been found to be present in as many as 25% ofpatients who carry a 'diagnosis' of hypertension.47" '8 Only the first few readings of 24-hour ambulatory blood pressure monitoring appear subject to this alerting response ( Figure 5 ) and averaging ofmultiple blood pressure readings both reduces the influence of these first few readings and reduces variability, thereby improving the estimate of true average blood pressure.49'`0 Hence, it would not be surprising if ambulatory blood pressure readings, averaged over 24-hours, over awake or over sleep periods, were better predictors ofcardiovascular risk than clinical readings. This important question has only been addressed by the study of Perloff and colleagues,5' who showed that patients with elevated clinic blood pressure readings but normal daytime values had a similar prognosis to subjects with normal clinical and normal daytime readings, while those with elevated clinical and elevated daytime ambulatory values were at greater risk of cardiovascular events and death. Two important multicentre European studies are currently underway, the 'Office versus Ambulatory Trial' (OvA)52 and the 'Systolic Hypertension in the Elderly Study' (SYST-EUR),52'5and both include in their aims the assessment of the correlation between treated 24-hour blood pressure and longterm prognosis.
In support of Perlofis unique study there are now many studies showing stronger correlations between hypertensive target organ damage and ambulatory pressures than between organ damage and clinic readings."63 As it is already well established that target organ damage in hypertension predicts cardiovascular risk,'-69 the likelihood is that the study ofPerloff et al., showing ambulatory blood pressure to be a better predictor for stroke, heart attack and death than clinical measurement, will soon be confirmed (Figure 7) .
It has been suggested that various patterns of blood pressure behaviour (Figures 1-6 ) might independently influence cardiovascular risk. Parati and colleagues70 have provided convincing evidence, from inter-arterial pressure studies, that short-term blood pressure variability is positively correlated with end organ damage independently of the average 24-hour pressure level -those individuals with an ambulatory blood pressure profile such as that in Figure 6 would be at greater risk oforgan damage and cardiovascular complications than those with a profile as in Figure 1 .
Blood pressure usually follows a circadian rhythm (Figures 1, 3_5) ,2427 with pressure levels higher during the day and lower at night. The usual nocturnal fall in blood pressure is diminished or absent in some subjects, and this has led to adoption of the terms 'dippers' (for the normal pattern) and 'non-dippers'. A blunted circadian pattern (Figure 2 atheromatous plaque.79-An excessive nocturnal reduction in blood pressure may critically reduce perfusion of vital organs, predisposing to cardiac,85-9' limb92 and cerebral ischaemia.9394 Hence, while it is very probable that mean 24-hour ambulatory blood pressure levels will prove to be a better predictor ofcardiovascular risk than clinical readings, the issue of the influence of spontaneous variability, circadian patterns, and night-time versus daytime blood pressure readings on morbidity and mortality is far from clear.
Twenty-four-hour blood pressure monitoring in clinical practice Ambulatory blood pressure measurement is currently evolving from being purely a research tool into clinical practice. In order to avoid misuse, it is essential that all operators have an understanding of the normal ranges of ambulatory blood pressure readings,95-98 as well as the typical moment-tomoment blood pressure variabilities42-"'99 and usual circadian rhythms. [24] [25] [26] [27] In addition, the operator must be familiar with the equipment and with the calibration procedures. He/she must be prepared to give the necessary time to instruct the subject so that as many measurements as possible are obtained during the recording period. Subjects for ambulatory blood pressure measurement must be capable of coping with and caring for the recorder. The conditions of measurement for the subject should be standardized as far as possible in relation to activity; in particular the arm should be held still during each measurement;1'°a similar level of activity should be undertaken for comparative repeat measurements; working days should not be compared with recreational days and likewise in shift workers, comparative measurements should be made between similar shifts.3233 The subjects should be asked to keep a diary of activities during the recording period, unless motion-logging, as an objective assessment of activity, is available.'0'
The clinical indications for using 24-hour noninvasive blood pressure measurement are best considered in relation to the diagnosis of hypertension or hypotension, and the selection and evaluation of anti-hypertensive drug treatment.
Diagnosis ofhypertension
Normal values over 24 hours for adults according to gender and age have now been defined. 95 98 Values for women during pregnancy are soon to be published.'02 Hence by comparison with this normative data, monitoring is particularly helpful in deciding whether subjects with a borderline elevation in clinical blood pressure should be labelled normotensive or hypertensive.'03 These subjects are currently likely to receive possibly unnecessary treatment on the basis ofclinical readings, and may be penalized for insurance cover and employment.' As mentioned above ambulatory monitoring is an effective non-invasive method ofdetermining whether blood pressure elevation is due solely to a white-coat effect. 47 If it is accepted that white-coat hypertensives do not need treatment, at least in the early stages, there is a prospect that 24-hour monitoring of blood pressure could be very cost-effective -the additional costs of the assessment would be more than offset by reductions in the numbers of patients perceived as needing anti-hypertensive drug treatment.'04 Elderly subjects with isolated systolic hypertension diagnosed by conventional methods are frequently found to have much reduced or essentially normotensive systolic pressures by ambulatory blood pressure monitoring.'05 The Syst-Eur study53
results, when available, should clarify if these patients with elevated clinical systolic readings but normal ambulatory systolic values are at increased cardiovascular risk, and whether they should receive any anti-hypertensive medication. Patients with secondary hypertension frequently exhibit a non-dipping ambulatory blood pressure profile as in Figure 2 but as many patients with essential hypertension also have blunted circadian rhythms, ambulatory monitoring can not be used as a specific screening test for secondary hypertension.l 06107
Although not proven as yet, hypertensive patients with both attenuated and excessive circadian swings in blood pressure may be at increased risk ofcardiovascular complications. 72 Secondly, an important difference between conventional and ambulatory blood pressure measurement is the absence of a placebo response with the latter."7"1'8 The placebo response, whereby the administration of placebo is associated with a reduction in blood pressure, may be an artifact of clinical blood pressure measurement due to the inherent variability of arterial pressure resulting in regression to the mean or may be due to increasing familiarity of the patient with the clinical environment. In uncontrolled drug studies where clinical blood pressures are used as the measure of response, the reduction in blood pressure due to a placebo response may be attributed erroneously to the drug. The absence of placebo response with noninvasive ambulatory measurement should facilitate simplification of the design of efficacy studies of anti-hypertensive drugs, in that long placebo phases may be omitted.
Thirdly, averaging the multiple blood pressure readings so as to obtain a mean 24-hour ambulatory blood pressure value reduces variability as compared to single clinic readings, thereby improving the repeatability of blood pressure estimations. 49 In a study by Conway and Coats on 75 subjects the standard deviation of the difference in diastolic pressure between two clinic readings taken a month apart was 12.3 mmHg.' On 24-hour monitoring this difference fell to 6.3 mmHg. Since the number of subjects needed in a trial is related to the square of the standard deviation of the difference, the improved repeatability leads to a substantial reduction in the number of subjects needed.
Lastly, and perhaps most importantly, ambulatory blood pressure monitoring can provide a comprehensive assessment of the pattern of antihypertensive drug effect over time,"19"120 clarifying their effects on circadian pattern,"11 and revealing any excessive lowering of blood pressure."3
In view of these many advantages ofambulatory blood pressure monitoring over clinical readings in the arena of clinical drug trials, it is somewhat surprising that the governmental regulating agencies in the United States and Europe have not approved, nor published guidelines for the use of ambulatory blood pressure monitoring in the evaluation of anti-hypertensive treatment, and have continued to seek casual blood pressure data alone. While the United States Food and Drugs Administration does not appear likely to approve ambulatory monitoring in the near future, as it finds that 'No drug development data have been submitted where ambulatory blood pressure data have been found useful in decision-making' proposals for European Commission guidelines that might make ambulatory pressure data a mandatory component of new drug applications, are being considered. '22 Conclusions Noninvasive blood pressure monitoring has so many advantages over other available methods of blood pressure evaluation in the clinical diagnosis and management of individual hypertensive patients, and in the evaluation of anti-hypertensive drug efficacy that the technique is now becoming established in clinical practice. The most important question now awaiting an answer is which of the many aspects of blood pressure behaviour that are now quantifiable by noninvasive 24-hour ambulatory monitoring, will prove best in predicting long-term morbidity and mortality.
